XBIT vs. XBIO
XBIT (XBiotech Inc.) and XBIO (Xenetic Biosciences, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, XBIT returned -16.62%/yr vs -42.70%/yr for XBIO. At a 0.07 correlation, their price movements are largely independent.
Performance
XBIT vs. XBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBIT achieves a -0.84% return, which is significantly lower than XBIO's 58.06% return. Over the past 10 years, XBIT has outperformed XBIO with an annualized return of -16.62%, while XBIO has yielded a comparatively lower -42.70% annualized return.
XBIT
- 1D
- -0.84%
- 1M
- -7.06%
- YTD
- -0.84%
- 6M
- -5.58%
- 1Y
- -19.39%
- 3Y*
- -24.92%
- 5Y*
- -30.49%
- 10Y*
- -16.62%
XBIO
- 1D
- 2.69%
- 1M
- 11.00%
- YTD
- 58.06%
- 6M
- 35.04%
- 1Y
- 11.70%
- 3Y*
- 2.82%
- 5Y*
- -31.95%
- 10Y*
- -42.70%
XBIT vs. XBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBIT XBiotech Inc. | -0.84% | -39.49% | -1.25% | 13.96% | -68.46% | -17.46% | -16.15% | 267.42% | 28.93% | -61.07% |
XBIO Xenetic Biosciences, Inc. | 58.06% | -45.61% | 15.65% | 21.01% | -77.90% | -36.76% | 41.67% | -92.68% | -14.54% | -55.37% |
Correlation
The correlation between XBIT and XBIO is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.07 |
Fundamentals
XBIT:
$72.26M
XBIO:
$7.86M
XBIT:
-$1.32
XBIO:
-$1.17
XBIT:
0.54
XBIO:
1.13
XBIT:
$0.00
XBIO:
$3.19M
XBIT:
-$805.00K
XBIO:
$2.38M
XBIT:
-$42.42M
XBIO:
-$2.37M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBIT vs. XBIO — Risk / Return Rank
XBIT
XBIO
XBIT vs. XBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and Xenetic Biosciences, Inc. (XBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XBIT | XBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.44 | ||
| Sortino ratioReturn per unit of downside risk | -1.99 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.21 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 0.15 | -0.64 |
| Martin ratioReturn relative to average drawdown | -0.75 | 0.20 | -0.94 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XBIT | XBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.38 | 0.07 | -0.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | -0.30 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.22 | -0.32 | +0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | -0.31 | +0.08 |
Drawdowns
XBIT vs. XBIO - Drawdown Comparison
The maximum XBIT drawdown since its inception was -92.67%, smaller than the maximum XBIO drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for XBIT and XBIO.
Loading charts...
Drawdown Indicators
| XBIT | XBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.67% | -99.95% | +7.28% |
Max Drawdown (1Y)Largest decline over 1 year | -39.43% | -80.50% | +41.07% |
Max Drawdown (3Y)Largest decline over 3 years | -78.56% | -80.50% | +1.94% |
Max Drawdown (5Y)Largest decline over 5 years | -87.21% | -96.19% | +8.98% |
Max Drawdown (10Y)Largest decline over 10 years | -90.72% | -99.78% | +9.06% |
Current DrawdownCurrent decline from peak | -91.27% | -99.91% | +8.64% |
Average DrawdownAverage peak-to-trough decline | -70.11% | -91.41% | +21.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.92% | 59.99% | -34.07% |
Volatility
XBIT vs. XBIO - Volatility Comparison
The current volatility for XBiotech Inc. (XBIT) is 6.88%, while Xenetic Biosciences, Inc. (XBIO) has a volatility of 12.44%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than XBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBIT | XBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.88% | 12.44% | -5.56% |
Volatility (6M)Calculated over the trailing 6-month period | 27.26% | 50.70% | -23.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.89% | 168.58% | -116.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.04% | 107.89% | -43.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.31% | 134.10% | -58.79% |
Dividends
XBIT vs. XBIO - Dividend Comparison
Neither XBIT nor XBIO has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
XBIO Xenetic Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBIT XBiotech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.46% |
Financials
XBIT vs. XBIO - Financials Comparison
This section allows you to compare key financial metrics between XBiotech Inc. and Xenetic Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
XBIT and XBIO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBIO has higher volatility (12.44%) compared to XBIT (6.88%). In terms of maximum drawdown, XBIT dropped -92.67% vs XBIO's -99.95%.
XBIO currently has the higher Sharpe Ratio (0.07 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBIT and XBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer